New scan could sharpen detection of liver cancer

NCT ID NCT06999837

Recruiting now Diagnosis Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a special PET/CT scan using a radioactive tracer called PSMA to get clearer images of liver cancer (HCC). Researchers want to see if this dynamic whole-body scan can better detect new or returning tumors compared to standard methods. Forty adults with liver cancer will be scanned, and the results will be compared with biopsies or follow-up scans over six months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: [68Ga]Ga-PSMA-11 (a radioactive tracer for PET scans)
What this could lead to: If successful, this imaging technique could help doctors more accurately detect and monitor liver cancer, potentially guiding better treatment decisions.
What could go wrong: This is a small, early-stage imaging study (40 participants) focused on diagnostic accuracy, not treatment. The new method may not prove significantly better than current scans.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HCC - HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HCC - HEPATOCELLULAR CARCINOMA

Contacts and locations

Locations

CHU de Nantes
RECRUITING

Nantes, France
HU Paris Nord APHP
NOT_YET_RECRUITING

Clichy, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.